Table 1.
Demographic Information and Laboratory Examination of Patients
| n | ||
|---|---|---|
| Sex | Male | 8 |
| Female | 5 | |
| Year of diagnosis | Before 2018 | 2 |
| 2018-Now | 11 | |
| Age at diagnosis | 67(60–72) | |
| Symptoms at diagnosis | Health examination | 7 |
| Abdominal pain | 5 | |
| Jaundice | 1 | |
| Alb(g/L) | 39.0(35.8–42.1) | |
| Tumor Marker | ||
| CA199(U/mL) | Normal | 8 |
| Abnormal | 4 | |
| Median(IQR) | 34.0(11.5–62.0) | |
| CEA(ng/mL) | Normal | 7 |
| Abnormal | 6 | |
| Median(IQR) | 3.0(2.4–11.8) | |
| AFP(ng/mL) | Normal | 12 |
| Abnormal | 0 | |
| Median(IQR) | 2.0(1.2–2.3) | |
| NSE(ng/mL) | Normal | 2 |
| Abnormal | 8 | |
| Median(IQR) | 23.0(21.5–26.0) |
Abbreviations: CA19-9, normal < 39 U/mL; CEA, normal < 4.7ng/mL; AFP, normal < 20ng/mL; NSE, neuron-specific enolase, normal <16.3ng/mL.